wordpress blog stats
Connect with us

Hi, what are you looking for?

US Govt Directs Biosense’s uChek To Seek FDA Approval

The US Food and Drug Administration (FDA) has asked GSF India-backed Biosense Technologies' iPhone based urine analysis app uChek to get a clearance for the app by the agency, reports Bloomberg, adding that this is the first time FDA has sent a letter to mobile based medical apps maker. For the uninitiated, uChek app is an urine analysis iOS app which can be used to test for 25 different medical conditions including diabetes, kidney, liver and bladder problems, pre-eclampsia and hypertension, and urinary tract infections. While the app is available as a free download on the Indian and the US app store, one needs to also purchase a uChek kit and urine dipsticks separately to conduct urine analysis through the app. The uChek kit is currently available for Rs 1,999 in India and $40 in the US, while the urine dipsticks is available at different price ranges starting at Rs 290 for 50 strips and going up to Rs 1596 for 100 strips. In a letter to Biosense, FDA says that the uChek Urine analyzer has been approved since it appears to meet the definition of a device as defined in section 201(h) of the Federal Food Drug and Cosmetic Act, however the uChek dipsticks which are made by Siemens and Bayer are approved only for direct visual reading and not automated analysis, due to which these dipsticks will require a new clearance for automated analysis. FDA says that it is currently unable to identify any Food and Drug Administration (FDA) clearance number for the uChek Urine analyzer and has asked the company to provide…

Please subscribe/login to read the full story.
Written By

MediaNama’s mission is to help build a digital ecosystem which is open, fair, global and competitive.

Views

News

India's smartphone operating system BharOS has received much buzz in the media lately, but does it really merit this attention?

News

After using the Mapples app as his default navigation app for a week, Sarvesh draws a comparison between Google Maps and Mapples

News

In the case of the ‘deemed consent' provision in the draft data protection law, brevity comes at the cost of clarity and user protection

News

The regulatory ambivalence around an instrument so essential to facilitate data exchange – the CM framework – is disconcerting for several reasons.

News

The provisions around grievance redressal in the Data Protection Bill "stands to be dangerously sparse and nugatory on various counts."

You May Also Like

News

Google has released a Google Travel Trends Report which states that branded budget hotel search queries grew 179% year over year (YOY) in India, in...

Advert

135 job openings in over 60 companies are listed at our free Digital and Mobile Job Board: If you’re looking for a job, or...

News

By Aroon Deep and Aditya Chunduru You’re reading it here first: Twitter has complied with government requests to censor 52 tweets that mostly criticised...

News

Rajesh Kumar* doesn’t have many enemies in life. But, Uber, for which he drives a cab everyday, is starting to look like one, he...

MediaNama is the premier source of information and analysis on Technology Policy in India. More about MediaNama, and contact information, here.

© 2008-2021 Mixed Bag Media Pvt. Ltd. Developed By PixelVJ

Subscribe to our daily newsletter
Name:*
Your email address:*
*
Please enter all required fields Click to hide
Correct invalid entries Click to hide

© 2008-2021 Mixed Bag Media Pvt. Ltd. Developed By PixelVJ